Page not found

Search results

  1. George Wilson from CTTC named to Harvard Business School 2022 Young American Leaders class

    ... director of new venture programs at the  Center for Technology Transfer and Commercialization , have been selected by  Global ...

    sommers - 06/23/2022 - 8:59am

  2. Vanderbilt licenses compound to Nashville’s Appello to advance Parkinson’s therapies

    ... start-up Appello Pharmaceuticals, Inc. to advance novel compounds developed by researchers in the  Vanderbilt Center for Neuroscience ... Parkinson’s disease was a golden opportunity to ensure our compounds get to patients.” Padma Raghavan, vice provost for research ...

    sommers - 10/22/2018 - 2:54pm

  3. Low-Frequency Strain Energy Harvester

    ... efficiently leverage human motion for energy using current technology. The proposed device overcomes this with ultrathin materials that ... mechanical bending and pressing motions of humans. Technology Description The mechanochemical strain harvester is ...

    cttc_admin - 02/02/2024 - 4:41pm

  4. Vanderbilt and 101st Airborne collaborate on development of exoskeleton for soldier use in Pathfinder Project

    ... Soldiers worked alongside Vanderbilt researchers, engineers, technology translation experts and other military partners to co-develop and ...

    sommers - 08/18/2022 - 9:14am

  5. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... a call with an advanced technology company providing NMR solutions in a variety of industries regarding ...

    steelmk - 11/15/2016 - 2:29pm

  6. ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders

    ... to VU319, the licensing agreement with ACADIA includes other compounds in preclinical development, as well as those in an ongoing discovery ... to de-risk novel mechanisms and advance beyond tool compounds to clinical candidates.” “This collaboration marks an ...

    sommers - 06/17/2020 - 3:17pm

  7. Prothena and Warren Center for Neuroscience Drug Discovery collaborate on new Alzheimer’s disease therapeutics

    ... Thomas Utley, senior licensing officer at the  Center for Technology Transfer and Commercialization . “The relationship among all ...

    sommers - 05/09/2022 - 9:10am

  8. Tech Connect, Vol. 7, Issue 7: CTTC welcomes UASP Fellow Tonny Omwansa

    ... of Nairobi. Tonny discussed innovation, entrepreneurship and technology transfer best practices with CTTC Licensing Officers and New ... Technology Spotlight: New Drug for Blood Clot: FXII Inhibitors ...

    steelmk - 11/10/2016 - 7:45am

  9. Four Vanderbilt Technologies Earn Patent Protection in February 2022

    ... Yan 11,242,342 Isoquinoline Amine Compounds as mGluR4 Allosteric Potentiators, Compositions, and Methods of ...

    sommers - 02/23/2022 - 9:14am

  10. Anti-inflammatory microparticles for sustained ocular drug delivery

    ... gold standard poly(lactic-co-glycolic acid) (PLGA). Technology Description To overcome these challenges, Vanderbilt ... They have validated these and prior versions of their technology in vitro using endotoxin and drug release kinetics assays; and in ...

    cttc_admin - 02/01/2024 - 12:21pm